13-[(4-Amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxybleomycinamide

13-[(4-Amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxybleomycinamide structure

CAS No.: 77368-64-0

Chemical Name:: 13-[(4-Amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxybleomycinamide

Synonyms: Talisomycin S6a;13-[(4-Amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxybleomycinamide;Bleomycinamide, 13-[(4-amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxy- (9CI);[2-[2-[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[5-[[1-[[1-(5-amino-3,4-dihydroxy-6-methyloxan-2-yl)oxy-2-[4-[4-[[4-amino-6-[3-(2-hydroxyethylamino)propylamino]-6-oxohexyl]carbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]-2-hydroxyethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-5-oxopentan-2-yl]amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate

CBNumber:: CB32272963

Molecular Formula:: C66H105N21O28S2

Molecular Weight:: 1704.81

MDL Number:

MOL File:: 77368-64-0.mol

Request For Quotation

13-[(4-Amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxybleomycinamide Properties

Density	1.61±0.1 g/cm3(Predicted)

13-[(4-Amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxybleomycinamide Preparation Products And Raw materials

Raw materials

Preparation Products

13-[(4-Amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxybleomycinamide Talisomycin S6a [2-[2-[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[[5-[[1-[[1-(5-amino-3,4-dihydroxy-6-methyloxan-2-yl)oxy-2-[4-[4-[[4-amino-6-[3-(2-hydroxyethylamino)propylamino]-6-oxohexyl]carbamoyl]-1,3-thiazol-2-yl]-1,3-thiazol-2-yl]-2-hydroxyethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-hydroxy-5-oxopentan-2-yl]amino]-1-(1H-imidazol-5-yl)-3-oxopropoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl] carbamate Bleomycinamide, 13-[(4-amino-4,6-dideoxy-α-L-talopyranosyl)oxy]-N1-[4-amino-6-[[3-[(2-hydroxyethyl)amino]propyl]amino]-6-oxohexyl]-19-demethyl-12-hydroxy- (9CI) 77368-64-0 C66H105N21O28S2